RA
NBIX icon

RFG Advisory’s Neurocrine Biosciences NBIX Stock Holding History

RFG Advisory’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.38M Buy
+8,195
New +$1.22M 0.02% 469

Other funds holding NBIX

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PBBUPS
PKO BP Bankowy Universal Pension Society Warsaw, Poland $350M AUM 272.18% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
EA
Ellsworth Advisors Hudson, Ohio $609M AUM 52.37% 1-Year Est. Return
P
PensionDanmark Copenhagen O, Denmark $12B AUM
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

RFG Advisory's NBIX Position: Q2 2026 in Review

RFG Advisory opened a new position in Neurocrine Biosciences (NBIX) in Q2 2026: 8,195 shares worth $1.38M. The stake represents 0.02% of the portfolio and ranks #469 among its holdings.

84 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • RFG Advisory held 8,195 shares of Neurocrine Biosciences worth $1.38M as of Q2 2026.
  • Neurocrine Biosciences was a new RFG Advisory position in Q2 2026.
  • Neurocrine Biosciences made up 0.02% of RFG Advisory's portfolio in Q2 2026, its #469 holding.
  • 84 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on RFG Advisory's 13F filing for Q2 2026, filed 15 Jul 2026.